The Effect of High-Dose Valsartan on Left Ventricular Function Following Primary Percutaneous Coronary Intervention

참고문헌 (6)

1. 김성식, "Evaluation of Cardiac Function by Transthoracic Echocardiography in Subjects with ST-Segment Elevation Myocardial Infarction Following Primary Percutaneous Coronary Intervention according to Valsartan Dose: The Valsartan One Center Trial", Journal of Cardiovascular Ultrasound, 18(3), pp.77~83 (2010), 한국심초음파학회
2. Antman EM, "American College of Cardiology; American Heart Association; Canadian Cardiovascular Society. ACC", AHA guidelines for the management of patients with STelevation myocardial infarction--executive summary. A report of the American College of Cardiology, J Am Coll Cardiol, pp.2004, 44[DOI]
3. Cohn JN, "Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure", N Engl J Med, 345, pp.1667~1675 (2001)
4. Pfeffer MA, "CHARM Investigators and Committees. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme", Lancet, 362, pp.759~766 (2003)
5. Konstam MA, "HEAAL Investigators. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial", Lancet, 374, pp.1840~1848 (2009)
6. Pfeffer MA, "Valsartan in Acute Myocardial Infarction Trial Investigators. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both", N Engl J Med, 349, pp.1893~1906 (2003)

관련 논문AI추천